Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2009 Mar 22;120(1):25–34. doi: 10.1007/s10549-009-0357-6

Figure 6. Evaluation of the malignancy-risk gene signature for breast lymph node development in Huang’s breast study.

Figure 6

(A) Area Under Curve (AUC) Calculation for Response Operating Characteristic Curve for the first PCA (p=0.0041). (B) Difference of the malignancy risk score between positive LN versus negative LN (p=0.0041).